ERO1's effect, in its capacity as a protein disulphide oxidase, is not restricted to VEGF but also to other angiogenic factors; thus, the consequence of its deficiency on the restraint of tumour angiogenesis might be highly effective (Manuelli et al., 2021; Varone et al., 2021). Here, VEGFA is linked to neoplasm.